A groundbreaking annual injection designed to protect against Human Immunodeficiency Virus (HIV) has successfully ...

Let’s take your partner’s HIV status out of the equation for a moment. You’re looking at a person who has a concerning temper, refuses to admit faults (and, therefore, probably refuses to work on them ...

Researchers from Imperial College London, working with the University of Oxford and Rockefeller University, have shown ...

Researchers led by Imperial have unveiled primary trial results that show encouraging advances in HIV treatment driven by ...

Gilead released data showing that an HIV drug, called lenacapavir, could provide virtually complete protection against ...

Pre-exposure prophylaxis (PrEP) is the advent of antiretroviral treatment use for people at increased risk of acquiring HIV-1 ...

An annual jab to protect against HIV “shows potential”, according to an early study. Millions of people around the world are ...

UN Engagement: UNAIDS and WHO have engaged with the Tanzania AIDS Commission to assess the impact and discuss fundraising modalities to continue ongoing activities. The UN Country Team has also ...

The Conference on Retroviruses and Opportunistic Infections 2025 opened with a session dedicated to informing attendees about ...

Dolutegravir is one of the most effective and safest HIV medicines and is used by millions of adults and adolescents living ...

Governments and global health groups are working to try to fill the most urgent gaps in the fight against diseases after the ...

SAN FRANCISCO -- Most patients with HIV who received two broadly neutralizing antibodies (bNAbs) after pausing antiretroviral ...